Leaders in psychedelic
drug development
Since 2017, Ceruvia Lifesciences, founded by Carey Turnbull, has focused on the discovery, development, and commercialization of transformational medicines to deliver meaningful relief to patients suffering from psychiatric and neurological disorders. Leveraging the expertise of some of the world’s leading medical schools, combined with a team of highly experienced drug development professionals, our clinical drug development program is creating new transformational medical breakthroughs.